相关实验视频
Updated: Jul 27, 2025

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.3K
低剂量纳尔特雷对非癌症集中性疼痛疾病的效用:一个范围审查
Adam Rupp1, Erin Young2, Andrea L Chadwick2
1Department of Physical Medicine and Rehabilitation, University of Kansas Medical Center, Kansas City, KS 66160, United States.
Pain medicine (Malden, Mass.)
|June 11, 2023
概括
低剂量纳尔特雷克森 (LDN) 通过调节神经炎症,在管理中央敏感性疼痛方面表现有前途. 需要进一步的研究来规范慢性疼痛病的LDN治疗方案.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 疼痛管理 疼痛管理
背景情况:
- 低剂量纳尔特雷 (LDN) 通过抑制中枢神经系统中微质激活来调节炎症.
- 微质细胞功能障碍是集中疼痛的关键因素.
- LDN是一种潜在的治疗药物,用于控制中心敏感性疼痛.
研究的目的:
- 综合现有的LDN数据,用于治疗各种集中疼痛疾病.
- 评估LDN作为一种新型治疗策略的有效性.
- 审查当前关于LDN在治疗耐火性疼痛方面的证据.
主要方法:
- 在PubMed,Embase和Google学者中进行全面的文献搜索.
- 研究的选择以叙事评论文章评估尺度 (SANRA) 标准为指导.
- 分析了47项已识别的研究,包括病例报告,叙事评论和随机对照试验.
主要成果:
- 有证据表明,LDN可以改善患者报告的疼痛,过敏症,身体功能,生活质量和睡眠.
- 观察到LDN剂量和患者反应时间的变化.
- 现有的随机对照试验很少,许多研究是病例报告或评论.
结论:
- 目前的证据支持LDN用于耐火性集中慢性疼痛.
- 需要进一步进行高质量的随机对照试验,以确定疗效和标准化治疗.
- 在慢性集中性疼痛条件下,LDN对管理疼痛和相关症状的持续承诺.
相关概念视频
Analgesia and Pain Management
668
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
668
Opioid Analgesics: Synthetic and Semisynthetic Opioids
348
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
348
Nociception
28.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.0K
Opioid Analgesics: Morphine and Other Natural Cogeners
302
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
302
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.4K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.4K
Opioid Receptors: Overview
1.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.1K

